Average Co-Inventor Count = 3.46
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (8 from 2,405 patents)
2. Abbvie Biotherapeutics Inc. (4 from 51 patents)
3. Full Spectrum Genetics, Inc. (3 from 5 patents)
4. Zymeworks Inc. (1 from 56 patents)
5. Merck Sharp + Dohme B.v. (1 from 55 patents)
15 patents:
1. 12441792 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
2. 12435133 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
3. 12122834 - Anti-PD-1 antibodies
4. 11958902 - Anti-TIGIT antibodies
5. 11111297 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
6. 11072658 - Anti-PD-1/LAG3 bispecific antibodies
7. 10947305 - Anti-TNFα binding compounds and uses thereof
8. 10865245 - Anti-B7H3 binding compounds and uses thereof
9. 10766957 - Anti-TIGIT antibodies
10. 10556957 - Anti-CD27 antibodies
11. 10150814 - Fc variants with improved complement activation
12. 9963509 - Anti-B7H3 binding compounds and uses thereof
13. 9587007 - CTLA4 proteins and their uses
14. 8883971 - CTLA4 proteins and their uses
15. 8642557 - CTLA4 proteins and their uses